These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
735 related items for PubMed ID: 25250833
21. Depression and risk of transformation of episodic to chronic migraine. Ashina S, Serrano D, Lipton RB, Maizels M, Manack AN, Turkel CC, Reed ML, Buse DC. J Headache Pain; 2012 Nov; 13(8):615-24. PubMed ID: 23007859 [Abstract] [Full Text] [Related]
22. Effects of switching acute treatment on disability in migraine patients using triptans. Serrano D, Buse DC, Kori SH, Papapetropoulos S, Cunanan CM, Manack AN, Reed ML, Lipton RB. Headache; 2013 Oct; 53(9):1415-29. PubMed ID: 23808937 [Abstract] [Full Text] [Related]
23. Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Serrano D, Manack AN, Reed ML, Buse DC, Varon SF, Lipton RB. Value Health; 2013 Oct; 16(1):31-8. PubMed ID: 23337213 [Abstract] [Full Text] [Related]
24. Depression and anxiety: effect on the migraine-obesity relationship. Tietjen GE, Peterlin BL, Brandes JL, Hafeez F, Hutchinson S, Martin VT, Dafer RM, Aurora SK, Stein MR, Herial NA, Utley C, White L, Khuder SA. Headache; 2007 Jun; 47(6):866-75. PubMed ID: 17578537 [Abstract] [Full Text] [Related]
25. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study. Holland S, Fanning KM, Serrano D, Buse DC, Reed ML, Lipton RB. J Neurol Sci; 2013 Mar 15; 326(1-2):10-7. PubMed ID: 23394974 [Abstract] [Full Text] [Related]
26. Endometriosis is associated with prevalence of comorbid conditions in migraine. Tietjen GE, Bushnell CD, Herial NA, Utley C, White L, Hafeez F. Headache; 2007 Mar 15; 47(7):1069-78. PubMed ID: 17635599 [Abstract] [Full Text] [Related]
27. Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention. Lipton RB, Silberstein SD. Headache; 2015 Mar 15; 55 Suppl 2():103-22; quiz 123-6. PubMed ID: 25662743 [Abstract] [Full Text] [Related]
28. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). Stokes M, Becker WJ, Lipton RB, Sullivan SD, Wilcox TK, Wells L, Manack A, Proskorovsky I, Gladstone J, Buse DC, Varon SF, Goadsby PJ, Blumenfeld AM. Headache; 2011 Mar 15; 51(7):1058-77. PubMed ID: 21762134 [Abstract] [Full Text] [Related]
29. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. J Neurol Neurosurg Psychiatry; 2010 Apr 15; 81(4):428-32. PubMed ID: 20164501 [Abstract] [Full Text] [Related]
30. Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study. Munjal S, Singh P, Reed ML, Fanning K, Schwedt TJ, Dodick DW, Buse DC, Lipton RB. Headache; 2020 Feb 15; 60(2):416-429. PubMed ID: 31837007 [Abstract] [Full Text] [Related]
31. Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design. Serrano D, Lipton RB, Scher AI, Reed ML, Stewart WBF, Adams AM, Buse DC. J Headache Pain; 2017 Oct 04; 18(1):101. PubMed ID: 28980171 [Abstract] [Full Text] [Related]
34. Migraine days decline with duration of illness in adolescents with transformed migraine. Bigal ME, Sheftell FD, Tepper SJ, Rapoport AM, Lipton RB. Cephalalgia; 2005 Jul 04; 25(7):482-7. PubMed ID: 15955034 [Abstract] [Full Text] [Related]
35. A 3-month analysis of disability, quality of life, and disease course in patients with migraine. Raggi A, Leonardi M, Bussone G, D'Amico D. Headache; 2013 Feb 04; 53(2):297-309. PubMed ID: 23094760 [Abstract] [Full Text] [Related]
36. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II). Blumenfeld AM, Bloudek LM, Becker WJ, Buse DC, Varon SF, Maglinte GA, Wilcox TK, Kawata AK, Lipton RB. Headache; 2013 Apr 04; 53(4):644-55. PubMed ID: 23458496 [Abstract] [Full Text] [Related]
37. Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention Study. Lipton RB, Munjal S, Buse DC, Bennett A, Fanning KM, Burstein R, Reed ML. Headache; 2017 Jul 04; 57(7):1026-1040. PubMed ID: 28603893 [Abstract] [Full Text] [Related]
38. Allodynia in migraine: association with comorbid pain conditions. Tietjen GE, Brandes JL, Peterlin BL, Eloff A, Dafer RM, Stein MR, Drexler E, Martin VT, Hutchinson S, Aurora SK, Recober A, Herial NA, Utley C, White L, Khuder SA. Headache; 2009 Oct 04; 49(9):1333-44. PubMed ID: 19788473 [Abstract] [Full Text] [Related]
39. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Headache; 2008 Sep 04; 48(8):1157-68. PubMed ID: 18808500 [Abstract] [Full Text] [Related]
40. Demographics, Headache Features, and Comorbidity Profiles in Relation to Headache Frequency in People With Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Buse DC, Reed ML, Fanning KM, Bostic RC, Lipton RB. Headache; 2020 Oct 14. PubMed ID: 33090481 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]